CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B Cell Lymphoma Model

Kutlu G. Elpek, Chantale Lacelle, Narendra P. Singh, Esma S. Yolcu, Haval Shirwan

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Tumors use a complex set off direct and indirect mechanisms to evade the immune system. Naturally arising CD4+CD25+FoxP3 + T regulatory (Treg) cells have been implicated recently in tumor immune escape mechanism, but the relative contribution of these cells to overall tumor progression compared with other immune evasion mechanisms remains to be elucidated. Using the A20 B cell lymphoma as a transplantable tumor model, we demonstrate that this tumor employs multiple direct (expression of immunoinhibitory molecule PD-L1, IDO, and IL-10, arid lack of expression of CD80 costimulatory molecule) and indirect (downregulation of APC function and induction of Treg cells) immune evasion mechanisms. Importantly, Treg cells served as the dominant immune escape mechanism early in tumor progression because the physical elimination of these cells before tumor challenge resulted in tumor-free survival in 70% of mice, whereas their depletion in animals with established tumors had no therapeutic effect. Therefore, our data suggest that Treg cells may serve as an important therapeutic target for patients with early stages of cancer and that more vigorous combinatorial approaches simultaneously targeting multiple immune evasion as well as immunosurveillance mechanisms for the generation of a productive immune response against tumor may be required for effective immunotherapy in patients with advanced disease.

Original languageEnglish (US)
Pages (from-to)6840-6848
Number of pages9
JournalJournal of Immunology
Volume178
Issue number11
StatePublished - Jun 1 2007

Fingerprint

Immune Evasion
B-Cell Lymphoma
Regulatory T-Lymphocytes
Neoplasms
Tumor Escape
Immunologic Monitoring
Therapeutic Uses
Interleukin-10
Immunotherapy
Immune System
Down-Regulation

ASJC Scopus subject areas

  • Immunology

Cite this

CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B Cell Lymphoma Model. / Elpek, Kutlu G.; Lacelle, Chantale; Singh, Narendra P.; Yolcu, Esma S.; Shirwan, Haval.

In: Journal of Immunology, Vol. 178, No. 11, 01.06.2007, p. 6840-6848.

Research output: Contribution to journalArticle

@article{4d0fdaa967a9419abf49307a5d9cb5f6,
title = "CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B Cell Lymphoma Model",
abstract = "Tumors use a complex set off direct and indirect mechanisms to evade the immune system. Naturally arising CD4+CD25+FoxP3 + T regulatory (Treg) cells have been implicated recently in tumor immune escape mechanism, but the relative contribution of these cells to overall tumor progression compared with other immune evasion mechanisms remains to be elucidated. Using the A20 B cell lymphoma as a transplantable tumor model, we demonstrate that this tumor employs multiple direct (expression of immunoinhibitory molecule PD-L1, IDO, and IL-10, arid lack of expression of CD80 costimulatory molecule) and indirect (downregulation of APC function and induction of Treg cells) immune evasion mechanisms. Importantly, Treg cells served as the dominant immune escape mechanism early in tumor progression because the physical elimination of these cells before tumor challenge resulted in tumor-free survival in 70{\%} of mice, whereas their depletion in animals with established tumors had no therapeutic effect. Therefore, our data suggest that Treg cells may serve as an important therapeutic target for patients with early stages of cancer and that more vigorous combinatorial approaches simultaneously targeting multiple immune evasion as well as immunosurveillance mechanisms for the generation of a productive immune response against tumor may be required for effective immunotherapy in patients with advanced disease.",
author = "Elpek, {Kutlu G.} and Chantale Lacelle and Singh, {Narendra P.} and Yolcu, {Esma S.} and Haval Shirwan",
year = "2007",
month = "6",
day = "1",
language = "English (US)",
volume = "178",
pages = "6840--6848",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "11",

}

TY - JOUR

T1 - CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early but not late phases of tumor development in a B Cell Lymphoma Model

AU - Elpek, Kutlu G.

AU - Lacelle, Chantale

AU - Singh, Narendra P.

AU - Yolcu, Esma S.

AU - Shirwan, Haval

PY - 2007/6/1

Y1 - 2007/6/1

N2 - Tumors use a complex set off direct and indirect mechanisms to evade the immune system. Naturally arising CD4+CD25+FoxP3 + T regulatory (Treg) cells have been implicated recently in tumor immune escape mechanism, but the relative contribution of these cells to overall tumor progression compared with other immune evasion mechanisms remains to be elucidated. Using the A20 B cell lymphoma as a transplantable tumor model, we demonstrate that this tumor employs multiple direct (expression of immunoinhibitory molecule PD-L1, IDO, and IL-10, arid lack of expression of CD80 costimulatory molecule) and indirect (downregulation of APC function and induction of Treg cells) immune evasion mechanisms. Importantly, Treg cells served as the dominant immune escape mechanism early in tumor progression because the physical elimination of these cells before tumor challenge resulted in tumor-free survival in 70% of mice, whereas their depletion in animals with established tumors had no therapeutic effect. Therefore, our data suggest that Treg cells may serve as an important therapeutic target for patients with early stages of cancer and that more vigorous combinatorial approaches simultaneously targeting multiple immune evasion as well as immunosurveillance mechanisms for the generation of a productive immune response against tumor may be required for effective immunotherapy in patients with advanced disease.

AB - Tumors use a complex set off direct and indirect mechanisms to evade the immune system. Naturally arising CD4+CD25+FoxP3 + T regulatory (Treg) cells have been implicated recently in tumor immune escape mechanism, but the relative contribution of these cells to overall tumor progression compared with other immune evasion mechanisms remains to be elucidated. Using the A20 B cell lymphoma as a transplantable tumor model, we demonstrate that this tumor employs multiple direct (expression of immunoinhibitory molecule PD-L1, IDO, and IL-10, arid lack of expression of CD80 costimulatory molecule) and indirect (downregulation of APC function and induction of Treg cells) immune evasion mechanisms. Importantly, Treg cells served as the dominant immune escape mechanism early in tumor progression because the physical elimination of these cells before tumor challenge resulted in tumor-free survival in 70% of mice, whereas their depletion in animals with established tumors had no therapeutic effect. Therefore, our data suggest that Treg cells may serve as an important therapeutic target for patients with early stages of cancer and that more vigorous combinatorial approaches simultaneously targeting multiple immune evasion as well as immunosurveillance mechanisms for the generation of a productive immune response against tumor may be required for effective immunotherapy in patients with advanced disease.

UR - http://www.scopus.com/inward/record.url?scp=34249785092&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249785092&partnerID=8YFLogxK

M3 - Article

C2 - 17513732

AN - SCOPUS:34249785092

VL - 178

SP - 6840

EP - 6848

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 11

ER -